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Background

Results

Methods

§ Fractionation regimens are defined in the planning
phase of radiotherapy (RT) to maximize tumor
destruction and minimize damage to surrounding
tissues. However, the planned dose is not accurate
in representing the delivered dose due to interfractional anatomical changes that occur during
treatment, such as tumor regression.

I.

4DCT
4DCTs images of
NSCLC patients were
imported to RayStation,
a treatment planning
system.

§ Dose accumulation can more accurately represent
the delivered dose. It consists of doses recomputed
on longitudinal images during treatment based on
the delivered fractions.
§ These recalculated doses are then mapped to a
reference image before being summed. The dose
mapping process depends on deformable image
registration (DIR), which establishes a voxel-voxel
correspondence between two images. However, the
precision of DIR can be affected by tumor response,
thus confounding the ability to estimate the total
dose delivered accurately. Tumor response is mainly
divided into inelastic regression: the tissue usually
remains intact and does not move along with the tumor
and elastic regression: the healthy tissue moves
concentrically with the tumor.

Work impact
§ To our knowledge, this will be the first workflow
in RT to define tumor regression. This will allow
more accurate delivered dose estimation which
can be linked to the toxicity information in followup images, ultimately improving treatment
outcomes.

Objective
§ To determine the fractionation scheme and identify
tumor regressions of non-small cell lung cancer
(NSCLC) patients treated with standard-fractionated
RT
using
weekly
four-dimensional
computed
tomography (4DCT) images.

Fractionation scheme determination

I. Fractionation scheme determination
Date

4DCT

Planning
7/13/2012
week

Accessed
MOSAIQ to view
the treatment
dates.

MOSAIQ fraction
dates examined
and matched with
4DCTs dates.

Date

Planning
7/13/2012
week

30

Week 1

7/25/2012

5

Week 2

8/1/2012

5

Week 3

8/8/2012

5

Week 1

7/25/2012

Week 2

8/1/2012

Week 3

8/8/2012

Week4

8/15/2012

Week4

8/15/2012

5

Week 5

8/22/2012

Week 5

8/22/2012

5

Week 6

8/29/2012

Week 6

8/29/2012

5

Table 1. Patient total 4DCTs
with corresponding dates.

• 65 fractionation schemes defined to
date.

Fraction
II.

• 16 patients have been evaluated for
tumor response to date.

Table 2. Completed fractionation scheme.

Tumor regression identification
Step 1

Planning week

Last week

• Physician
approved
gross
tumor volume (GTV) contours
(purple) in the planning week.
•

• For
each
patient,
four
landmarks were placed at
vessel bifurcations around the
tumor to classify inelastic or
elastic change. Inelastic cases
were defined if the tumor
regressed while the surrounding
normal tissue remains intact,
and elastic regressions were
defined if the tumor regressed
with the surrounding normal
tissue moving concentrically
with the tumor border.

GTV
LW

Percent
change

Type of
regression

9.63

5.8

-39%

inelastic

11.09

5.04

-54%

inelastic

44.22

32.76

-25%

inelastic

Conclusions

Step 2
• Evaluation of the GTV
percent change.

Using deep-learning based
automatically segmented GTV
contour (green) in the last
week, the GTV volume change
was quantified.
Step 3

GTV
PW

Table 3. Sample summary of tumor regression
identification. The rest of the data can be
provided to the interested reader.

Fig 1. Fractionation assigning.

II.

Tumor regression identification

GTV percent
change
evaluation
Fig 2. Tumor regression identification in planning week and last week 4DCTs of one NSCLC
case.

This work will facilitate the
determination of the accumulated
dose at each week where 4DCTs
were taken.

II. The tumor regression identification
will reduce the inaccuracy of image
registrations, improving accuracy
of delivered dose estimation.

Future directions
Lower than
-25%

Regression,
go to step 3.

Fig 3. Planning and last week 4DCTs of one NSCLC case with landmarks around the tumor.

I.

• Improve the robustness of the
identification of the type of regression
for difficult cases where tumor have
non-uniform changes.
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